Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty Acid Metabolism

Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty Acid Metabolism

Satoko Kawarasaki,1 Honami Sawazaki,1 Hiroaki Iijima,2 Su-Ping Ng,1 Jungin Kwon,1 Shinsuke Mohri,1 Mari Iwase,1 Huei-Fen Jheng,1 Haruya Takahashi,1 Wataru Nomura,1,3 Kazuo Inoue,1,3 Teruo Kawada,1,3 Tsuyoshi Goto1,3 1Laboratory of Molecular Function of Food, Division of Food Science and Biotechnolog...

Full description

Bibliographic Details
Main Authors: Kawarasaki S, Sawazaki H, Iijima H, Ng SP, Kwon J, Mohri S, Iwase M, Jheng HF, Takahashi H, Nomura W, Inoue K, Kawada T, Goto T
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
sglt2 inhibitor
obesity
dosing method
Online Access:https://www.dovepress.com/comparative-analysis-of-the-preventive-effects-of-canagliflozin-a-sodi-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/comparative-analysis-of-the-preventive-effects-of-canagliflozin-a-sodi-peer-reviewed-article-DMSO

Similar Items